Inhibition by cholera toxin of the antilipolytic action of prostanoids, N6-(phenylisopropyl) adenosine and insulin.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000241:Adenosine / Q000031:analogs & derivatives*; D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000527:Alprostadil; D000818:Animals; D002772:Cholera Toxin / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism; D011464:Epoprostenol / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D007328:Insulin / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology; D008066:Lipolysis / Q000187:drug effects*; D008297:Male; D010660:Phenylisopropyladenosine / Q000494:pharmacology*; D011453:Prostaglandins / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains
D005230:Fatty Acids, Nonesterified; D007328:Insulin; D011453:Prostaglandins; D011458:Prostaglandins E; D010660:Phenylisopropyladenosine; D002772:Cholera Toxin; D011464:Epoprostenol; D000242:Cyclic AMP; D000527:Alprostadil; D000241:Adenosine; D007545:Isoproterenol; D015056:1-Methyl-3-isobutylxanthine